ISI Web of Knowledge Take the next step  
Web of Science®
 
Previous Record (inactive) Record 1  of  1 Next Record (inactive)
Record from Web of Science®
CHEMOTHERAPY PROLONGS SURVIVAL IN INOPERABLE PANCREATIC-CARCINOMA
Author(s): PALMER KR, KERR M, KNOWLES G, CULL A, CARTER DC, LEONARD RCF
Source: BRITISH JOURNAL OF SURGERY    Volume: 81    Issue: 6    Pages: 882-885    Published: JUN 1994  
Times Cited: 176     References: 22     
Abstract: Forty-three patients with irrescetable advanced pancreatic cancer were randomized to receive chemotherapy using a combination of 5-fluorouracil, Adriamycin and mitomycin or no chemotherapy. Groups were well matched with regard to age, extent of disease and performance status on entry. Chemotherapy was well tolerated and, although common, side-effects were usually mild. Psychological measurements based on the Hospital Anxiety and Depression score were made in 31 patients. These showed significantly less depression but not anxiety in the treated group immediately after randomization and following 2 months of chemotherapy. Median survival in the treated group was 33 (range 9-80) weeks compared with 15 (range 1-62) weeks in the untreated group (P < 0.002). Chemotherapy should be considered in all patients presenting with advanced inoperable pancreatic cancer.
Document Type: Article
Language: English
Reprint Address: PALMER, KR (reprint author), WESTERN GEN HOSP, GASTROINTESTINAL UNIT, GASTRINTESTINAL ANNEXE, CREWE RD, EDINBURGH EH4 2XU, MIDLOTHIAN SCOTLAND
Addresses:
1. WESTERN GEN HOSP, DEPT CLIN ONCOL, EDINBURGH EH4 2XU, MIDLOTHIAN SCOTLAND
2. WESTERN GEN HOSP, DEPT PSYCHOL, EDINBURGH EH4 2XU, MIDLOTHIAN SCOTLAND
3. UNIV EDINBURGH, ROYAL INFIRM, DEPT SURG, EDINBURGH, SCOTLAND
Publisher: BLACKWELL SCIENCE LTD, OSNEY MEAD, OXFORD, OXON, ENGLAND OX2 0EL
Subject Category: Surgery
IDS Number: NR792
ISSN: 0007-1323
Previous Record (inactive) Record 1  of  1 Next Record (inactive)
Record from Web of Science®
  
Thomson Reuters Logo